Fevery Pharma SRL
Fevery Pharma reported total assets of €1.50m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Fevery Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +19 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fevery Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Fevery Pharma's financial analysis
- Solvency78.4%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fevery Pharma
Fevery Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0552.675.811
- VAT number
- BE0552675811
- Peppol
- Registered · 0208:0552675811 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 May 2014
- Registered office
- 8000 Bruges
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Fevery Pharma (SRL) has been based in Bruges since 2014, active in: activities of holding companies. For 2025, it reports a net profit of 160,584 € and equity of €1.18m; its revenue is not published. Its solvency stands at 78.4%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Fevery Pharma
Companies in the same business, of comparable size and area, outside its group.
- Staur Activities of holding companies Evergem · balance sheet €1.50m
- Halyco Activities of holding companies Geel · balance sheet €1.08m
- MDB-23 Activities of holding companies Antwerp · balance sheet €2.20m
- Antwerpse Participatiemaatschappij Activities of holding companies Antwerp · balance sheet €2.33m
- GLM Trading Activities of holding companies Antwerp · balance sheet €2.41m
- Carpentier Consulting & Support Activities of holding companies Ostend · balance sheet €2.50m
- VIA Lucca Activities of holding companies Jabbeke · balance sheet 893,638 €
- GDRCH Activities of holding companies Tournai · balance sheet 859,818 €
Frequently asked questions about Fevery Pharma
What is the revenue of Fevery Pharma?
Fevery Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fevery Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0552675811 for Fevery Pharma, if the company is VAT-registered. Its company number (CBE) is 0552.675.811.
Where is the registered office of Fevery Pharma?
According to the CBE register, the registered office of Fevery Pharma is in 8000 Bruges.
What is the equity of Fevery Pharma?
At the close of the 2025 financial year, the equity of Fevery Pharma amounts to 1,179,015 €, a solvency of 78.4% of total assets.
Who manages Fevery Pharma?
The register lists 4 active mandates at Fevery Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Fevery Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →